Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study of Davutamig (REGN5093) for Patients with Advanced Non-Small Cell Lung Cancer with MET Alterations
FranceStudy on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors
AustriaStudy on the Effects of EVX-01 and Pembrolizumab in Adults with Advanced Melanoma
ItalyStudy of Letetresgene Autoleucel for Patients with Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
FranceStudy of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials
ItalyStudy of ASP1570 Alone or with Pembrolizumab for Adults with Advanced Solid Tumors
FranceStudy of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments
ItalyStudy on Adding Zoledronic Acid or Denosumab to Radiotherapy for Adults with Inoperable Vertebral Bone Metastases
FranceStudy on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors
CzechiaStudy on Sotorasib for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with KRAS Mutation
SpainStudy of trametinib and hydroxychloroquine in patients with metastatic pancreatic cancer that has not responded to previous treatment
IrelandStudy on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors
DenmarkThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
